![](https://s3.amazonaws.com/cache.altmetric.com/policy/thumbnails/thumbnail-4d6ef69fedb7a811f726424bd6083602b26fdf5ee50742a324a3dd8f1a8ca182.jpg)
Biomarker-Based Point-of-Care Tests for the Evaluation of Mild Traumatic Brain Injury
Cited by Canadian Agency for Drugs and Technologies in Health on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.